Piramal Healthcare Buys Rights To Sell Germany’s PlasmaSelect
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - India's Piramal Healthcare said it has bought the global rights to market blood plasma products of Germany-based PlasmaSelect for an undisclosed amount in a deal that excludes the company's manufacturing unit at Marburg, Germany